Answer to yesterday’s quiz: In the HALT-PKD study, the annual percentage increase in total kidney volume (the primary outcome) was significantly lower in which one of the following treatment groups? A. The lisinopril–placebo group. B. The lisinopril–telmisartan group. C. The group assigned to a low blood-pressure target. D. The group assigned to a standard blood-pressure target. The answer is C. The annual percentage increase in total kidney volume was significantly lower in the low blood-pressure group than in the standard-blood-pressure group, without significant differences between the lisinopril–telmisartan group and the lisinopril–placebo group. Participants in the low-blood-pressure group had a 14.2% slower annual increase in total kidney volume, as compared with those in the standard-blood-pressure group (5.6% vs. 6.6%, P = 0.006). The total kidney volume increased at similar rates in the lisinopril–telmisartan group and the lisinopril–placebo group (6.0% per year and 6.2% per year, respectively; P = 0.52). nej.md/1BTvjkw
Posted on: Tue, 16 Dec 2014 14:00:01 +0000
Trending Topics
© 2015